Abstract
A novel class of inhibitors of the hepatitis C virus [substituted 2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridines] is described. Introduction of a fluorine in position 2 of the 2-phenyl substituent of the lead anti-pestivirus compound 1 (5-[(4-bromophenyl)methyl]-2-phenyl-5H-imidazo[4,5-c]pyridine) resulted in an analogue with selective activity against HCV in the subgenomic replicon system.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Antiviral Agents / chemical synthesis*
-
Antiviral Agents / pharmacology*
-
Cytopathogenic Effect, Viral / drug effects
-
Diarrhea Viruses, Bovine Viral / drug effects
-
Drug Design
-
Drug Evaluation, Preclinical
-
Hepacivirus / drug effects*
-
Humans
-
Imidazoles / chemical synthesis*
-
Imidazoles / pharmacology*
-
Magnetic Resonance Spectroscopy
-
Mass Spectrometry
-
Pestivirus / drug effects*
-
Pyridines / chemical synthesis*
-
Pyridines / pharmacology*
-
Replicon
-
Structure-Activity Relationship
Substances
-
Antiviral Agents
-
Imidazoles
-
Pyridines